BioSpace News Archive

Business

Vertex Leans into Gene Editing Space with Extended Arbor Pact

Vertex and Arbor Biotechnologies extend partnership in precision gene editing.

January 12, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Oramed’s Insulin Capsule Fails Its First Phase III Trial

Oramed, a clinical-stage company developing orally available versions of biologic drugs, reported disappointing news regarding its lead candidate, ORMD-0801.

January 12, 2023
·
1 min read
·
Cory Renauer
Business

New Verily Life Sciences CEO to Cut 15% of Staff, Shake Up C-Suite

Verily Life Sciences, a unit of Alphabet Inc. formerly known as Google Life Sciences, plans to undergo a restructuring that includes cutting about 15% of its workforce and shaking up its C-Suite.

January 12, 2023
·
1 min read
·
Rosemary Scott
Ionis Envisions Two New Approvals in 2023 in ALS and ATTRv-PN

At JPM Wednesday, Ionis CEO Brett Monia touted nine positive late- and mid-stage readouts from 2022 and set up the company’s commercial prospects for 2023.

January 12, 2023
·
1 min read
·
Heather McKenzie
Genetown

Aitia and G3 Therapeutics Publish Results Identifying New Causal Biomarkers of Atherosclerotic Coronary Artery Disease (ASCAD), the Leading Cause of Morbidity and Mortality Worldwide

G3 Therapeutics and Aitia, the leader in the application of Causal AI and “Digital Twins” to discover and develop new drugs, today announced results of research that identified new causes of ASCAD.

January 12, 2023
·
5 min read
Biotech Beach

Biolase Receives Top Workplaces 2022 Award

BIOLASE, Inc., the global leader in dental lasers, announced that the Company has been awarded a Top Workplaces 2022 honor by the Orange County Register Top Workplaces.

January 12, 2023
·
4 min read
BioCapital

Gain Therapeutics to Present at Sidoti Small-Cap Virtual Investor Conference

Gain Therapeutics, Inc. will present a corporate update at the Sidoti Small-Cap Virtual Investor Conference on Wednesday, January 18 at 2:30 PM ET.

January 12, 2023
·
4 min read
Silence Therapeutics Provides SLN360 and SLN124 Clinical Program Updates

Silence Therapeutics plc today provided the following SLN360 and SLN124 program updates during a presentation at the 41st Annual J.P. Morgan Healthcare Conference.

January 12, 2023
·
4 min read
Business

Mr. David Gryska Appointed to Forte Biosciences Board of Directors

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), announced today that Mr. David Gryska has been appointed to the Forte Biosciences Board of Directors.

January 12, 2023
·
4 min read
Biotech Beach

Puma Biotechnology to Present at B. Riley Securities’ 3rd Annual Oncology Conference

Puma Biotechnology, Inc. will provide an overview of the Company at 11:00 a.m. PST/2:00 p.m. EST on January 19 at the virtual B. Riley Securities’ 3rd Annual Oncology Conference.

January 12, 2023
·
2 min read